• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在冠状动脉旁路移植术后,经心脏磁共振评估无确诊心肌梗死情况下心肌坏死生物标志物的异常升高。

Abnormal elevation of myocardial necrosis biomarkers after coronary artery bypass grafting without established myocardial infarction assessed by cardiac magnetic resonance.

作者信息

Oikawa Fernando Teiichi Costa, Hueb Whady, Nomura Cesar Higa, Hueb Alexandre Ciappina, Villa Alexandre Volney, da Costa Leandro Menezes Alves, de Melo Rodrigo Morel Vieira, Rezende Paulo Cury, Segre Carlos Alexandre Wainrober, Garzillo Cibele Larrosa, Lima Eduardo Gomes, Ramires Jose Antonio Franchini, Filho Roberto Kalil

机构信息

Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.

出版信息

J Cardiothorac Surg. 2017 Dec 29;12(1):122. doi: 10.1186/s13019-017-0684-3.

DOI:10.1186/s13019-017-0684-3
PMID:29284532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5747262/
Abstract

BACKGROUND

The diagnosis of peri-procedural myocardial infarction is complex, especially after the emergence of high-sensitivity markers of myocardial necrosis.

METHODS

In this study, patients with normal baseline cardiac biomarkers and formal indication for elective on-pump coronary bypass surgery were evaluated. Electrocardiograms, cardiac biomarkers, and cardiac magnetic resonance imaging with late gadolinium enhancement were performed before and after procedures. Myocardial infarction was defined as more than ten times the upper reference limit of the 99th percentile for troponin I and for creatine kinase isoform (CK-MB) and by the findings of new late gadolinium enhancement on cardiac magnetic resonance. We assessed the release of cardiac biomarkers in patients with no evidence of myocardial infarction on cardiac magnetic resonance.

RESULTS

Of 75 patients referred for on-pump coronary bypass surgery, 54 (100%) did not have evidence of myocardial infarction on cardiac magnetic resonance. However, all had a peak troponin I above the 99th percentile; 52 (96%) had an elevation 10 times higher than the 99th percentile. Regarding CK-MB, 54 (100%) patients had a peak CK-MB above the 99th percentile limit, and only 13 (24%) had an elevation greater than 10 times the 99th percentile. The median value of troponin I peak was 3.15 (1.2 to 3.9) ng/mL, which represented 78.7 times the 99th percentile.

CONCLUSION

In this study, different from CK-MB findings, troponin was significantly increased in the absence of myocardial infarction on cardiac magnetic resonance. Thus, CK-MB was more accurate than troponin I for excluding procedure-related myocardial infarction. These data suggest a higher troponin cutoff for the diagnosis of coronary bypass surgery related myocardial infarction.

CLINICAL TRIAL REGISTRATION

http://www.isrctn.com/ISRCTN09454308 . Registered 08 May 2012.

摘要

背景

围手术期心肌梗死的诊断较为复杂,尤其是在心肌坏死高敏标志物出现之后。

方法

在本研究中,对基线心脏生物标志物正常且有择期体外循环冠状动脉搭桥手术正式指征的患者进行了评估。在手术前后进行了心电图、心脏生物标志物检测以及延迟钆增强心脏磁共振成像检查。心肌梗死的定义为肌钙蛋白I和肌酸激酶同工酶(CK-MB)超过第99百分位数上限参考值的十倍以上,以及心脏磁共振上出现新的延迟钆增强表现。我们评估了心脏磁共振上无心肌梗死证据的患者心脏生物标志物的释放情况。

结果

在75例接受体外循环冠状动脉搭桥手术的患者中,54例(100%)在心脏磁共振上无心肌梗死证据。然而,所有患者的肌钙蛋白I峰值均高于第99百分位数;52例(96%)升高至高于第99百分位数的10倍以上。关于CK-MB,54例(100%)患者的CK-MB峰值高于第99百分位数上限,只有13例(24%)升高大于第99百分位数的10倍。肌钙蛋白I峰值的中位数为3.15(1.2至3.9)ng/mL,为第99百分位数的78.7倍。

结论

在本研究中,与CK-MB结果不同,心脏磁共振上无心肌梗死时肌钙蛋白显著升高。因此,CK-MB在排除手术相关心肌梗死方面比肌钙蛋白I更准确。这些数据提示在诊断冠状动脉搭桥手术相关心肌梗死时应采用更高的肌钙蛋白临界值。

临床试验注册

http://www.isrctn.com/ISRCTN09454308 。2012年5月8日注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/5747262/53d37708409f/13019_2017_684_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/5747262/e72d7207572f/13019_2017_684_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/5747262/9ca8675bccde/13019_2017_684_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/5747262/0f6bd9cc9382/13019_2017_684_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/5747262/53d37708409f/13019_2017_684_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/5747262/e72d7207572f/13019_2017_684_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/5747262/9ca8675bccde/13019_2017_684_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/5747262/0f6bd9cc9382/13019_2017_684_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/5747262/53d37708409f/13019_2017_684_Fig4_HTML.jpg

相似文献

1
Abnormal elevation of myocardial necrosis biomarkers after coronary artery bypass grafting without established myocardial infarction assessed by cardiac magnetic resonance.在冠状动脉旁路移植术后,经心脏磁共振评估无确诊心肌梗死情况下心肌坏死生物标志物的异常升高。
J Cardiothorac Surg. 2017 Dec 29;12(1):122. doi: 10.1186/s13019-017-0684-3.
2
Accuracy of Myocardial Biomarkers in the Diagnosis of Myocardial Infarction After Revascularization as Assessed by Cardiac Resonance: The Medicine, Angioplasty, Surgery Study V (MASS-V) Trial.心脏磁共振评估血运重建后心肌生物标志物在心肌梗死诊断中的准确性:药物、血管成形术、手术研究V(MASS-V)试验
Ann Thorac Surg. 2016 Jun;101(6):2202-8. doi: 10.1016/j.athoracsur.2015.11.034. Epub 2016 Feb 22.
3
Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.通过心脏磁共振延迟钆增强评估的无确诊心肌梗死患者经皮冠状动脉介入术后生物标志物的释放情况。
Catheter Cardiovasc Interv. 2017 Jul;90(1):87-93. doi: 10.1002/ccd.27125. Epub 2017 Jun 2.
4
With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention.采用“通用定义”,通过测量肌酸激酶-心肌带而非肌钙蛋白,可更准确地诊断冠状动脉介入治疗后的围手术期坏死和梗死。
J Am Coll Cardiol. 2011 Feb 8;57(6):653-61. doi: 10.1016/j.jacc.2010.07.058.
5
Significant elevation of biomarkers of myocardial necrosis after coronary artery bypass grafting without myocardial infarction established assessed by cardiac magnetic resonance.通过心脏磁共振评估发现,在未发生心肌梗死的冠状动脉旁路移植术后,心肌坏死生物标志物显著升高。
Medicine (Baltimore). 2017 Feb;96(6):e6053. doi: 10.1097/MD.0000000000006053.
6
Use of biochemical markers of infarction for diagnosing perioperative myocardial infarction and early graft occlusion after coronary artery bypass surgery.使用梗死生化标志物诊断冠状动脉搭桥手术后围手术期心肌梗死及早期移植物闭塞。
Chest. 2002 Jan;121(1):103-11. doi: 10.1378/chest.121.1.103.
7
Cardiac troponin I in diagnosis of perioperative myocardial infarction after cardiac surgery.心肌肌钙蛋白I在心脏手术后围手术期心肌梗死诊断中的应用
J Cardiothorac Vasc Anesth. 1998 Jun;12(3):288-94. doi: 10.1016/s1053-0770(98)90008-8.
8
Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.冠状动脉搭桥术后伴或不伴围手术期心肌梗死患者中心肌肌钙蛋白I与T及肌酸激酶同工酶MB的比较
Herz. 2004 Nov;29(7):658-64. doi: 10.1007/s00059-004-2543-y.
9
Evaluation of postoperative myocardial injury by heart-type fatty acid-binding protein in off-pump coronary artery bypass grafting surgery.心脏型脂肪酸结合蛋白在非体外循环冠状动脉旁路移植术中对术后心肌损伤的评估
Rev Esp Anestesiol Reanim. 2015 Jan;62(1):3-9. doi: 10.1016/j.redar.2014.02.011. Epub 2014 Apr 18.
10
Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial.心脏生物标志物升高的预后评估假设、原理、设计和方法,经皮和手术血运重建后无明显心肌梗死。生物标志物和心脏磁共振的比较分析。MASS-V 试验。
BMC Cardiovasc Disord. 2012 Aug 16;12:65. doi: 10.1186/1471-2261-12-65.

引用本文的文献

1
Developments in Extracellular Matrix-Based Angiogenesis Therapy for Ischemic Heart Disease: A Review of Current Strategies, Methodologies and Future Directions.基于细胞外基质的缺血性心脏病血管生成疗法的进展:当前策略、方法及未来方向综述
BioTech (Basel). 2025 Mar 19;14(1):23. doi: 10.3390/biotech14010023.

本文引用的文献

1
Cardiac markers of myocardial necrosis: a history and discussion of milestones and emerging new trends.心肌坏死的心脏标志物:历史回顾及里程碑与新趋势探讨
Clin Lab Med. 2014 Mar;34(1):31-41, xi. doi: 10.1016/j.cll.2013.11.001. Epub 2014 Jan 14.
2
Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI.经高敏肌钙蛋白 T 和新的心电图或超声心动图改变诊断 CABG 后的 MI:与死亡率的关系和 MI 的通用定义的验证。
Eur Heart J Acute Cardiovasc Care. 2013 Dec;2(4):323-33. doi: 10.1177/2048872613496941. Epub 2013 Aug 5.
3
Early troponin T and prediction of potentially correctable in-hospital complications after coronary artery bypass grafting surgery.
早期肌钙蛋白 T 与冠状动脉旁路移植术后潜在可纠正的院内并发症预测。
PLoS One. 2013 Sep 6;8(9):e74241. doi: 10.1371/journal.pone.0074241. eCollection 2013.
4
Third universal definition of myocardial infarction.心肌梗死的第三次全球定义。
J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98. doi: 10.1016/j.jacc.2012.08.001. Epub 2012 Sep 5.
5
Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial.心脏生物标志物升高的预后评估假设、原理、设计和方法,经皮和手术血运重建后无明显心肌梗死。生物标志物和心脏磁共振的比较分析。MASS-V 试验。
BMC Cardiovasc Disord. 2012 Aug 16;12:65. doi: 10.1186/1471-2261-12-65.
6
Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?肌钙蛋白升高的病理生物学:升高是否同时发生于心肌缺血和坏死?
J Am Coll Cardiol. 2011 Jun 14;57(24):2406-8. doi: 10.1016/j.jacc.2011.01.029.
7
Biochemical markers in acute coronary syndrome.急性冠状动脉综合征的生化标志物。
Clin Chim Acta. 2011 Jul 15;412(15-16):1279-96. doi: 10.1016/j.cca.2011.04.003. Epub 2011 Apr 8.
8
Utility of cardiac biomarkers for the diagnosis of type V myocardial infarction after coronary artery bypass grafting: insights from serial cardiac MRI.心脏生物标志物在冠状动脉旁路移植术后 5 型心肌梗死诊断中的应用:连续心脏 MRI 的见解。
Heart. 2011 May;97(10):810-6. doi: 10.1136/hrt.2010.213462. Epub 2011 Mar 4.
9
Myocardial injury following coronary artery surgery versus angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging.冠状动脉搭桥术与经皮冠状动脉介入治疗术后心肌损伤(MICASA):应用生化标志物和心脏磁共振成像的随机试验。
EuroIntervention. 2011 Jan;6(6):703-10. doi: 10.4244/EIJV6I6A119.
10
World Health Organization definition of myocardial infarction: 2008-09 revision.世界卫生组织心肌梗死定义:2008-2009 年修订版。
Int J Epidemiol. 2011 Feb;40(1):139-46. doi: 10.1093/ije/dyq165. Epub 2010 Oct 5.